Tomizawa D, Matsubayashi J, Iwamoto S, Hiramatsu H, et al. High-dose cytarabine induction therapy and flow cytometric measurable residual disease monitoring for children with acute myeloid leukemia. Leukemia 2023 Nov 6. doi: 10.1038/s41375-023-02075.
PMID: 37926712